Press release
Creative Diagnostics Introduces Advanced Hepatitis Virus Animal Models to Accelerate HBV Drug and Vaccine Development
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its Hepatitis Virus Animal Model [https://antiviral.creative-diagnostics.com/hepatitis-virus-animal-model.html] services, to provide researchers and pharmaceutical partners with the tools for detailed investigations into disease progression, immune responses and the development of novel interventions for chronic Hepatitis B Virus (HBV) infection.
The hepatitis B virus is a potent pathogen capable of inducing chronic infections that lead to multiple liver diseases, including acute and chronic hepatitis, cirrhosis, and particularly primary hepatocellular carcinoma, which poses a significant health threat in the Asia-Pacific region. Although currently approved antiviral therapies (including pegylated interferon [IFN] and nucleoside [nucleotide] analogues) effectively suppress viremia, HBV infection is rarely cured.
Given HBV's narrow species tropism, infecting only humans and higher primates with high efficiency, the scarcity of suitable animal models has severely hampered HBV research and preclinical testing of antiviral drugs. Fortunately, a series of alternative animal models have been successfully developed for HBV research. An in-depth understanding of barriers to cross-species transmission has driven the creation of human chimeric mice, opening a crucial pathway for in vivo HBV studies and the evaluation of potential therapies for chronic hepatitis B.
HBV is a prototypical member of the Hepadnaviridae family, which encompasses other hepatotropic viruses, such as the duck hepatitis B virus (DHBV) and the woodchuck hepatitis virus (WHV). While DHBV and HBV are distantly related, readily available primary duck hepatocytes and ducklings have been invaluable in elucidating the unique replication mechanisms of hepadnaviruses and evaluating antiviral therapeutics. Furthermore, WHV is a pivotal model for studying chronic infection and hepatocellular carcinoma progression and is widely used to evaluate antiviral and immunotherapeutic regimens.
Creative Diagnostics now provides sophisticated animal models for studying hepatitis viruses, particularly HBV. These models facilitate the creation of controlled experimental systems for the in-depth investigation of disease progression, immune responses and the development of novel interventions for chronic HBV infection. Moreover, Creative Diagnostics offers customized animal models to support the unique requirements of each research programme.
HBV is primarily transmitted through blood and blood products. Creative Diagnostics' specialist team prepares infection solutions using HBV patient sera or HBV DNA, which are then injected into animals. The company primarily uses ducks, woodchucks and mice to create models for hepatitis virus research. These models include HBV Full-Genome Pseudovirus-Infected Mouse Models, Duck Hepatitis B Virus (DHBV) Infection Liver Necrosis Models, Duck Hepatitis B Virus (DHBV) Infection Models, and Woodchuck Hepatitis Virus (WHV) Infection Models.
Creative Diagnostics also offers a range of services to support hepatitis virus animal model studies, including custom study design, pathological analysis, immune response profiling, and detailed in vivo pharmacokinetic (PK) and pharmacodynamic (PD) evaluations.
For more information on these models or related innovative solutions for preclinical research involving infectious diseases, please visit https://antiviral.creative-diagnostics.com/hepatitis-virus-animal-model.html.
About Creative Diagnostics
Headquartered in New York, Creative Diagnostics is a consulting and experimental service provider specializing in virology and microbiology. The company provides comprehensive solutions to conquer obstacles in virology and microbiology research, from high-security infrastructure provision, biosafety regulation elucidation, to expert viral system assistance.
Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=creative-diagnostics-introduces-advanced-hepatitis-virus-animal-models-to-accelerate-hbv-drug-and-vaccine-development]
Country: United States
Website: https://antiviral.creative-diagnostics.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Creative Diagnostics Introduces Advanced Hepatitis Virus Animal Models to Accelerate HBV Drug and Vaccine Development here
News-ID: 4315901 • Views: …
More Releases from ABNewswire
MT Dunn Plumbing Expands Emergency Services in Hillsboro & Across Portland, Oreg …
MT Dunn Plumbing LLC (CCB# 234243) expands 24/7 emergency services across Hillsboro, Beaverton, Portland & Washington County. The licensed, bonded, and insured contractor provides immediate response for burst pipes, water heater failures, sewer backups, and drain clogs. Operating from Hillsboro, owner Michael T Dunn serves residential and commercial properties region-wide. Emergency contact: 503-640-2458 or mtdunnplumbing.com.
Hillsboro, OR - MT Dunn Plumbing LLC, a licensed and established plumbing contractor serving the Portland…
Beyond the Prompt: How Mimic Motion Architecture is Redefining the 2026 Passive …
Image: https://www.abnewswire.com/upload/2026/02/ac57e1a7b6e53a95f52ea0f18fcb990c.jpg
As we move through 2026, the digital economy is no longer just about "what" you show, but "how" it moves. Static content is losing ground to kinetic, motion-driven narratives that capture attention in seconds. At the center of this shift is Loova, whose proprietary Mimic Motion architecture has become the secret engine behind some of the most successful passive income streams this year.
This report breaks down the technical logic…
The Real Cost of Convenience: A Complete Guide to Vending Machine Startup Costs
Image: https://www.abnewswire.com/upload/2026/02/32ec9ac40420df59e70c21070d981def.jpg
The dream of earning passive income often leads aspiring entrepreneurs to the world of automated retail. It is a sector defined by low labor requirements and the ability to generate revenue around the clock. However, before you can stock your first row of snacks, you must understand the financial commitment required to get your equipment on-site. Many beginners find themselves asking how much do vending machines cost [https://dfyvending.com/vending-machine-startup-costs] as…
Benji Personal Injury Surpasses 1,000 Cases Won as California Accident Victims S …
Benji Personal Injury Accident Attorneys, A.P.C. has surpassed 1,000 personal injury cases resolved across California, reflecting a growing demand for trialready legal representation. The firm's litigationfirst approach has led to multimilliondollar verdicts and settlements, helping accident victims secure significantly higher compensation through courtroomfocused preparation.
LOS ANGELES, CA - Benji Personal Injury Accident Attorneys, A.P.C. announced today that the firm has successfully resolved over 1,000 personal injury cases, marking a significant milestone…
More Releases for HBV
Emerging Hepatitis B Virus (HBV) Market Trends: Rising Emphasis On Highly Sensit …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Hepatitis B Virus (HBV) Market Size Growth Forecast: What to Expect by 2025?
The market for the hepatitis B virus (HBV) has expanded significantly in the last few years. The market is set to grow from its size of $6.71 billion in 2024 to an anticipated $7.37 billion in…
HIV/HBV/HCV Test Kits Market - Break the chain: Detect and prevent HIV, HBV, and …
Newark, New Castle, USA: The "HIV/HBV/HCV Test Kits Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
HIV/HBV/HCV Test Kits Market: https://www.growthplusreports.com/report/hivhbvhcv-test-kits-market/8774
This latest report researches the industry structure,…
Hepatitis B Virus [HBV] Treatment market ready to register a 5.30% CAGR
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Executive Summary -:
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Hepatitis B Treatment Market by Type (Therapeutics and Vaccines), By End-User (Male and Female) for the regions (North America, Europe, Asia—Pacific and ROW) and By Country (U.S., Canada,…
Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)
Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain…
Rising Prevalence of HBV and HCV Drives the Global Hepatitis Diagnostics Market
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E.…
Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)
Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain…
